• Home
  • NEW DAY MEDICINE
  • 12 (62) 2023
  • 16 -12 (62) 2023 — Хayrullaeva D.Kh., Yuldosheva D.Kh. — DIAGNOSTIC SIGNIFICANCE OF CLINICAL AND OBJECTIVE SIGNS IN CHRONIC VIRAL HEPATITIS C

16 -12 (62) 2023 — Хayrullaeva D.Kh., Yuldosheva D.Kh. — DIAGNOSTIC SIGNIFICANCE OF CLINICAL AND OBJECTIVE SIGNS IN CHRONIC VIRAL HEPATITIS C

DIAGNOSTIC SIGNIFICANCE OF CLINICAL AND OBJECTIVE SIGNS IN CHRONIC VIRAL HEPATITIS C

Хayrullaeva D.Kh., Bukhara State Medical Institute named after Abu Ali ibn Sina

Yuldosheva D.Kh. Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

This article describes the prevalence and clinical features of 120 patients with chronic hepatitis. As a result of the study, it was found that the disease is more common in women and the different picture of subjective or objective symptoms is higher in patients.

Key words: chronic hepatitis, liver, virus, subjective sign, objective sign

First page

79

Last page

82

For citation: Хayrullaeva D.Kh., Yuldosheva D.Kh. – DIAGNOSTIC SIGNIFICANCE OF CLINICAL AND OBJECTIVE SIGNS IN CHRONIC VIRAL HEPATITIS C //New Day in Medicine 2023 12(62): 79-82 https://newdaymedicine.com/index.php/2023/12/10/l-570/

LIST OF REFERENCES:

  1. Журавлева Л.В. Применение эластографии у больных хроническими заболеваниями печени / Л.В. Журавлева, Е.В. Огнева // Гастроэнтерология. 2018;52:98-103.
  2. Ивашкин В.Т. Гастроэнтерология: национальное руководство / В.Т. Ивашкин, Т.Л. Лапина. – / М.: ГЭОТАР-Медиа, 2015;480.
  3. Подымова С.Д. Болезни печени: руководство для врачей / С.Д. Подымова. – Изд. 5-е, перераб. и доп. — Москва: ООО «Медицинское информационное агентство», 2018;984.
  4. Xamrayev А.А., Yuldosheva D.X., Zokirov V.Z., Muxammedova Z.R. Clinical-laboratory markers of progression of non-alcoholic fatty liver disease // American Journal of Medicine and Medical Sciences. – USA, 2021;11(5):419-425.
  5. Xamrayev А.А., Yuldosheva D.X., Шамсиева Т.Т., Хайдаров Д.Б. Diagnostic significance of molecular-genetic markers in the development of non-alcoholic fatty liver disease // Тиббиётда янги кун журнали. Тошкент, 2022;9(47):374-381.
  6. Yuldasheva D.H. Shadjanova N.S., Oltiboyev R.O.Non-alcoholic fatty liver disease and modern medicine // Academicia an international multidisciplinary research journal Nov. 2020;10(11):1931-1937.
  7. Yuldasheva D.H., Zokirov V.Z., G`ulomova Sh.Q. Non-alcoholic fatty liver disease: Modern view of the problem // A Multidisciplinary Peer Reviewed Journal. Dec. 2020;6(12):286-292.
  8. Yuldosheva D.X. Diagnostic significance of laboratory markers, inflammatory and anti – inflammatory cytokines in the development of non-alcoholic fatty liver disease steatosis and steatohepatitis // British Medical Journal, 2022;3:26-35.
  9. Yuldosheva D.X. Prevalence of non- alcoholic fatty liver disease,
    clinical and laboratory markers // Eurasian journal of medical and natural sciences. Tashkent. 2022;94-100.
  10. Yuldosheva D.X. Reletionship to the refluxate type of the effectiveness of treatment degree of gastroesophageal reflux disease // European Journal of Research. Austria, Vienna. 2019;2:110-114.
  11. Yuldosheva D.X., Zokirov V.Z., G`ulomova Sh.Q. Non-alcoholic fatty liver: modern view of the problem // Multidisciplinary Peer reviewed journal. India. 2020;6(12):286-292.

file

download